We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Diagnostics Firm For QS, CAPA Deficiencies
FDA Cites Diagnostics Firm For QS, CAPA Deficiencies
September 7, 2006
After finding numerous violations of the quality system regulation, the FDA issued a warning letter to diagnostics manufacturer San Ramon, Calif.-based BioGenex.